使用蛋白质半合成策略阐明C终端后翻译性修饰的作用:α-synuclein在tyrosine 125的酸化
Mirva Hejjaoui1, Sara Butterfield, Bruno Fauvet
1Laboratory of Molecular and Chemical Biology of Neurodegeneration, Brain Mind Institute, Ecole Polytechnique Fédérale de Lausanne (EPFL), CH-1015 Lausanne, Switzerland.
Journal of the American Chemical Society
|February 21, 2012
概括
研究人员开发了一种新方法,通过后翻译修改 (PTMs) 精确修改α-synuclein (α-syn). 这使得研究特定的PTM,如酸化,如何影响α-syn聚合和疾病中的功能.
科学领域:
- 生物化学 生物化学
- 神经科学是一个神经科学.
- 分子生物学分子生物学
背景情况:
- 翻译后修饰 (PTMs) 影响α-synuclein (α-syn) 聚合和毒性,但它们的具体作用和调节仍然不清楚.
- 现有的方法缺乏对PTM,特别是酸铁的引入进行特定地点的控制,这阻碍了功能研究.
- 识别选择性α-syn酸化的激酶至关重要,但具有挑战性.
研究的目的:
- 开发一种多功能半合成策略,用于在α-syn.中特定地点引入PTM.
- 用于制备同质的,C-终端修饰的α-syn变体,以毫克的数量.
- 研究选择性Y125酸化对α-syn结构,聚合,膜结合和局部化的影响.
主要方法:
- 开发了一个通用和高效的半合成策略.
- 启用了单个或多个PTM的特定站点引入.
- 准备的同质C-终端修饰的α-syn,量为毫克.
主要成果:
- 成功地将PTMs引入α-syn.中,包括在Y125的选择性酸化.
- 这使得首次对特定于特定地点的Y125酸化的影响进行了调查.
- 为详细的结构和功能分析提供同质的α-syn变体.
结论:
- 开发的半合成方法允许精确地将PTM引入α-syn.
- 这一进展对于理解PTM在α-syn生物学和疾病中的作用至关重要.
- 促进对α-syn PTMs在健康和神经退行性疾病中的未来研究.
相关概念视频
Phosphorylation
The addition or removal of phosphate groups from proteins is the most common chemical modification that regulates cellular processes. These modifications can affect the structure, activity, stability, and localization of proteins within cells as well as their interactions with other proteins.
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
Covalently Linked Protein Regulators
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein.
These groups modify specific amino acids in a protein.
Protein Modifications in the RER
Modification of secretory and transmembrane proteins entering the rough ER begins in the ER lumen. These modifications aid in protein folding and stabilize the acquired tertiary structure. Protein modifications in the rough ER co-occur at different stages of protein folding.
Broadly, these modifications can be categorized into four main categories — glycosylation, formation of disulfide bonds, assembly of protein subunits, and specific proteolytic cleavages like removal of signal sequences.
Broadly, these modifications can be categorized into four main categories — glycosylation, formation of disulfide bonds, assembly of protein subunits, and specific proteolytic cleavages like removal of signal sequences.
Protein Kinases and Phosphatases
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...


